- Home
- NYXH
NYXH
Nyxoah SA
as of 12-18-2025 3:46pm EST
$4.64
$0.17
-3.44%
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Chart Type:
Time Range:
| Founded: | 2009 | Country: | Belgium |
| Employees: | N/A | City: | N/A |
| Market Cap: | 188.1M | IPO Year: | 2021 |
| Target Price: | $12.67 | AVG Volume (30 days): | 46.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.34 - $11.87 | Next Earning Date: | 11-13-2025 |
| Revenue: | $6,616,215 | Revenue Growth: | 10.96% |
| Revenue Growth (this year): | 79.25% | Revenue Growth (next year): | 297.08% |
AI-Powered NYXH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 71.72%
71.72%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Nyxoah SA News
NYXH Breaking Stock News: Dive into NYXH Ticker-Specific Updates for Smart Investing
GlobeNewswire
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
📈
AI Sentiment
Highly Positive
9/10
Compare NYXH vs Leading Stocks
See how NYXH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NYXH Nyxoah SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.